![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, October 04, 2012 3:22:02 PM
EKNL NEWS!!! - Hitting Walmart stores!
NeroVasc Clinical Inc. Awareness Campaign
2012-10-04 09:45 ET - News Release
BURLINGTON, ON, Oct. 4, 2012 /PRNewswire/ - EKO International Inc. (EKNL-Pinksheets) announces that NeuroVasc Clinical Inc.,( NCI) is commencing an awareness campaign notifying health care practitioners that clinics providing treatment for Diabetic Peripheral Neuropathy will soon be available for their patients. Diabetic neuropathies, affect over 50% of diabetics. If left untreated, diabetic neuropathies trigger foot ulcers that may require amputation, may cause disabling chronic pain and may increase the risk of falling to the elderly. The annual cost of diabetic neuropathies has been estimated at $14 billion in the United States.
The treatment of Diabetic Peripheral Neuropathy is the main intended use for the proprietary FREMS device now being distributed in North America by NCI.
NCI also distributes the NC-Stat DPN check device which is a point of care nerve conduction measurement tool essential in the early detection of peripheral neuropathy. Patients who score poorly on the nerve conduction test are prime candidates for FREMS treatments and this is very valuable information for Physicians, Pharmacists , Podiatrists and Certified Diabetic Educators .
EKO, NeuroVasc Medical Inc. and NCI will continue to support the Canadian and American Diabetes Associations' call for the annual testing of all diabetics for peripheral neuropathy and will work to educate the community about the role FREMs can play in treating neuropathy and in preventing leg ulcers and their devastating complications.
Of interest is the following quote:
"Is the testing service now available to the general public and where can it be found?
The product is relatively new to the market having been introduced late last year. Through the end of June, we've placed 590 devices with physicians and health care professionals in North America, including WalMart-Canada pharmacies where the test is offered as a part of a comprehensive foot examination at 100 of their stores.
Also, the large San-Antonio, Texas based managed care organization, WellMed, has adopted the technology and plans to test its patient population numbering about 100,000. "-News Medical-http://www.news-medical.net/news/20120806/Medical-devices-for-diabetic-peripheral-neuropathy-an-interview-with-Dr-Shai-Gozani-CEO-of-NeuroMetrix.aspx
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM